Role of MIF in Hepatic Inflammatory Diseases and Fibrosis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-319-52354-5_7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration.

  2015cited by this paper
• Macrophage migration inhibitory factor is required for recruitment of scar‐associated macrophages during liver fibrosis

  2015cited by this paper
• Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies

  2015cited by this paper
• Hepatic inflammation and fibrosis: Functional links and key pathways

  2015cited by this paper
• Pathobiology of liver fibrosis: a translational success story

  2015cited by this paper
• Nonalcoholic fatty liver disease: a systematic review.

  2015cited by this paper
• MIF interacts with CXCR7 to promote receptor internalization, ERK1/2 and ZAP‐70 signaling, and lymphocyte chemotaxis

  2015cited by this paper
• Macrophage Migration Inhibitory Factor Is Detrimental in Pneumococcal Pneumonia and a Target for Therapeutic Immunomodulation.

  2015cited by this paper
• CD74 expression and its therapeutic potential in thyroid carcinoma.

  2015cited by this paper
• Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver

  2015cited by this paper
• Macrophage migration inhibitory factor involvement in breast cancer (Review)

  2015cited by this paper
• Liver fibrosis: Common mechanisms and antifibrotic therapies.

  2015cited by this paper
• AUTOIMMUNE , CHOLESTATIC AND BILIARY DISEASE The Role of Macrophage Migration Inhibitory Factor in Autoimmune Liver Disease

  2014cited by this paper
• Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation

  2014cited by this paper
• Macrophage Migration Inhibitory Factor Deficiency Ameliorates High-Fat Diet Induced Insulin Resistance in Mice with Reduced Adipose Inflammation and Hepatic Steatosis

  2014cited by this paper
• Roles for chemokines in liver disease.

  2014cited by this paper
• Significance of the vascular endothelial growth factor and the macrophage migration inhibitory factor in the progression of hepatocellular carcinoma.

  2014cited by this paper
• The Expression of HIV-1 Vpu in Monocytes Causes Increased Secretion of TGF-β that Activates Profibrogenic Genes in Hepatic Stellate Cells

  2014cited by this paper
• Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis

  2014cited by this paper
• Translational approaches: from fatty liver to non-alcoholic steatohepatitis.

  2014cited by this paper
• Effect of extracellular vesicles of human adipose tissue on insulin signaling in liver and muscle cells

  2014cited by this paper
• IL28B polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients.

  2014cited by this paper
• Involvement of exercise-induced macrophage migration inhibitory factor in the prevention of fatty liver disease

  2013cited by this paper
• Influence of the human MIF promoter polymorphism on hepatocellular carcinoma prognosis.

  2013cited by this paper
• Immune surveillance by the liver

  2013cited by this paper
• Macrophage migration inhibitory factor contributes to ethanol‐induced liver injury by mediating cell injury, steatohepatitis, and steatosis

  2013cited by this paper
• Kinetics of the inflammatory response induced by free fatty acid accumulation in hepatocytes.

  2013cited by this paper
• Relationship between MIF-173 G/C polymorphism and susceptibility to chronic hepatitis B and HBV-induced liver cirrhosis.

  2013cited by this paper
• Current developments of macrophage migration inhibitory factor (MIF) inhibitors.

  2013cited by this paper
• Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumab.

  2013cited by this paper
• Alcoholic liver disease: Pathogenesis, management, and novel targets for therapy

  2013cited by this paper
• Kupffer cells in the liver.

  2013cited by this paper
• Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance.

  2013cited by this paper
• Liver transplantation: past, present and future

  2013cited by this paper
• Milatuzumab-Conjugated Liposomes as Targeted Dexamethasone Carriers for Therapeutic Delivery in CD74+ B-cell Malignancies

  2012cited by this paper
• Macrophage migration inhibitory factor is elevated in obese adolescents

  2012cited by this paper
• MIF, MIF Alleles, and Prospects for Therapeutic Intervention in Autoimmunity

  2012cited by this paper
• Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance

  2012cited by this paper
• Sterile inflammation in the liver.

  2012cited by this paper
• Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats.

  2012cited by this paper
• The Role of Chemokines in Acute Liver Injury

  2012cited by this paper
• Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid‐induced apoptosis

  2012cited by this paper
• Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74

  2011cited by this paper
• RANTES antagonism: a promising approach to treat chronic liver diseases.

  2011cited by this paper
• Alcoholic liver disease: pathogenesis and new therapeutic targets.

  2011cited by this paper
• Hyperglycemic Myocardial Damage Is Mediated by Proinflammatory Cytokine: Macrophage Migration Inhibitory Factor

  2011cited by this paper
• Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.

  2011cited by this paper
• Hypoxia‐inducible factor‐1α regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis

  2011cited by this paper
• Inflammatory Adipokines, High Molecular Weight Adiponectin, and Insulin Resistance: A Population-Based Survey in Prepubertal Schoolchildren

  2011cited by this paper
• Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma

  2011cited by this paper
• Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74.

  2011cited by this paper
• Macrophage migration inhibitory factor is a therapeutic target in treatment of non‐insulin‐dependent diabetes mellitus

  2010cited by this paper
• Macrophage migration inhibitory factor expression and MIF gene −173 G/C polymorphism in nonalcoholic fatty liver disease

  2010cited by this paper
• Up-regulation of MicroRNA-155 in Macrophages Contributes to Increased Tumor Necrosis Factor α (TNFα) Production via Increased mRNA Half-life in Alcoholic Liver Disease*

  2010cited by this paper
• Fatty liver disease in children: eat now pay later

  2010cited by this paper
• Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment

  2010cited by this paper
• Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

  2010cited by this paper
• Macrophage migration inhibitory factor mediates the antidepressant actions of voluntary exercise

  2010cited by this paper
• Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice.

  2010cited by this paper
• A functional heteromeric MIF receptor formed by CD74 and CXCR4

  2009cited by this paper
• Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.

  2009cited by this paper
• Immunohistochemical study of macrophage migration inhibitory factor in rat liver fibrosis induced by thioacetamide.

  2009cited by this paper
• MIF Deficiency Reduces Chronic Inflammation in White Adipose Tissue and Impairs the Development of Insulin Resistance, Glucose Intolerance, and Associated Atherosclerotic Disease

  2009cited by this paper
• Insulin sensitivity: modulation by nutrients and inflammation.

  2008cited by this paper
• Mechanisms of Disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis

  2008cited by this paper
• Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis

  2008cited by this paper
• Chemokine-like functions of MIF in atherosclerosis

  2008cited by this paper
• LPS/TLR4 signal transduction pathway.

  2008cited by this paper
• Signal Transduction (1930 articles)

  2007cited by this paper
• MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

  2007cited by this paper
• Liver: An organ with predominant innate immunity

  2007cited by this paper
• Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases.

  2007cited by this paper
• Hepatic Neutrophil Infiltration in the Pathogenesis of Alcohol-Induced Liver Injury

  2007cited by this paper
• Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment.

  2007cited by this paper
• The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity.

  2007cited by this paper
• Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma.

  2006cited by this paper
• The effects of macrophage migratory inhibitory factor on acute-phase protein production in primary human hepatocytes.

  2006cited by this paper
• Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4).

  2006cited by this paper
• Lack of macrophage migration inhibitory factor protects mice against concanavalin A‐induced liver injury

  2006cited by this paper
• Macrophage Migration Inhibitory Factor Induces Macrophage Recruitment via CC Chemokine Ligand 21

  2006cited by this paper
• Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.

  2005cited by this paper
• Role for macrophage migration inhibitory factor in asthma.

  2005cited by this paper
• New therapeutic target in inflammatory disease: macrophage migration inhibitory factor

  2005cited by this paper
• Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin.

  2004cited by this paper
• The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

  2003cited by this paper
• MIF Signal Transduction Initiated by Binding to CD74

  2003cited by this paper
• Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4)

  2003cited by this paper
• Macrophage migration inhibitory factor: a regulator of innate immunity

  2003cited by this paper
• Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride

  2003cited by this paper
• Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.

  2002cited by this paper
• Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations.

  2002cited by this paper
• Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice.

  2002cited by this paper
• A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis

  2002cited by this paper
• Macrophage migration inhibitory factor expression in male and female ethanol-fed rats.

  2001cited by this paper
• Role of macrophage migration inhibitory factor (MIF) in murine antigen‐induced arthritis: interaction with glucocorticoids

  2001cited by this paper
• Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis.

  2001cited by this paper
• Increased serum levels of macrophage migration inhibitory factor in alcoholic liver diseases and their expression in liver tissues.

  2001cited by this paper
• MIF regulates innate immune responses through modulation of Toll-like receptor 4

  2001cited by this paper
• Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes.

  2000cited by this paper
• Cytokines in alcoholic and nonalcoholic steatohepatitis.

  2000cited by this paper

• Macrophage Inhibitory Factor in Myocardial Oxidative Stress and Inflammation During Thioacetamide-Induced Liver Fibrosis: Modulation by Betaine

  2025cites this paper
• The Role of Macrophage Inhibitory Factor in TAA-Induced Liver Fibrosis in Mice: Modulatory Effects of Betaine

  2024cites this paper
• Assessment of Serum Macrophage Migration Inhibitory Factor (MIF) as an Early Diagnostic Marker of Leptospirosis

  2022cites this paper
• Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells

  2020cites this paper
• Macrophage migration inhibitory factor contributes to the pathogenesis of benign lymphoepithelial lesion of the lacrimal gland

  2018cites this paper